Disc Medicine Stock (NASDAQ:IRON)
Previous Close
$47.13
52W Range
$25.60 - $77.60
50D Avg
$48.56
200D Avg
$47.57
Market Cap
$1.73B
Avg Vol (3M)
$215.06K
Beta
0.18
Div Yield
-
IRON Company Profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
IRON Performance
Peer Comparison
Ticker | Company |
---|---|
ANAB | AnaptysBio, Inc. |
DICE | DICE Therapeutics, Inc. |
OLMA | Olema Pharmaceuticals, Inc. |
MORF | Morphic Holding, Inc. |
CNTA | Centessa Pharmaceuticals plc |
LRMR | Larimar Therapeutics, Inc. |
MLYS | Mineralys Therapeutics, Inc. |
BMEA | Biomea Fusion, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
ACRV | Acrivon Therapeutics, Inc. Common Stock |
OBIO | Orchestra BioMed Holdings, Inc. |
FENC | Fennec Pharmaceuticals Inc. |
TERN | Terns Pharmaceuticals, Inc. |
TRDA | Entrada Therapeutics, Inc. |
CRNX | Crinetics Pharmaceuticals, Inc. |
MLTX | MoonLake Immunotherapeutics |
ABOS | Acumen Pharmaceuticals, Inc. |
GPCR | Structure Therapeutics Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
ADAG | Adagene Inc. |
AMLX | Amylyx Pharmaceuticals, Inc. |